DK1495051T3 - Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler - Google Patents

Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Info

Publication number
DK1495051T3
DK1495051T3 DK03723513T DK03723513T DK1495051T3 DK 1495051 T3 DK1495051 T3 DK 1495051T3 DK 03723513 T DK03723513 T DK 03723513T DK 03723513 T DK03723513 T DK 03723513T DK 1495051 T3 DK1495051 T3 DK 1495051T3
Authority
DK
Denmark
Prior art keywords
fibrinogen
fibrin
properties
lmw
hmw
Prior art date
Application number
DK03723513T
Other languages
Danish (da)
English (en)
Inventor
Maat Monica Petronella Maria De
Pieter Koolwijk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of DK1495051T3 publication Critical patent/DK1495051T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/046Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03723513T 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler DK1495051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.
PCT/NL2003/000293 WO2003087160A1 (fr) 2002-04-18 2003-04-07 Modification des proprietes d'une matrice de fibrine par rapport a la croissance et a l'interposition des cellules

Publications (1)

Publication Number Publication Date
DK1495051T3 true DK1495051T3 (da) 2008-11-10

Family

ID=29244993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03723513T DK1495051T3 (da) 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Country Status (10)

Country Link
US (2) US7867519B2 (fr)
EP (1) EP1495051B1 (fr)
JP (3) JP5083928B2 (fr)
AT (1) ATE403679T1 (fr)
AU (1) AU2003230455A1 (fr)
CA (1) CA2482893C (fr)
DE (1) DE60322687D1 (fr)
DK (1) DK1495051T3 (fr)
NL (1) NL1020426C2 (fr)
WO (1) WO2003087160A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004208038B2 (en) 2003-01-30 2007-09-06 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8329870B2 (en) 2007-01-04 2012-12-11 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009111069A1 (fr) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Produits de recombinaison spongieux, particules de cartilage et associations de produits de recombinaison spongieux et de particules de cartilage
CA2730030C (fr) 2008-07-09 2019-09-03 Profibrix Bv Fibrinogene recombine
WO2011083153A2 (fr) 2010-01-08 2011-07-14 Profibrix Bv Préparations de fibrinogène enrichies en fibrinogène doté d'une chaîne alpha allongée
NZ600812A (en) * 2010-01-08 2014-08-29 Profibrix Bv Dry powder fibrin sealant
WO2012140650A2 (fr) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugués de carboxy polysaccharides avec des facteurs de croissance des fibroblastes et variants de ceux-ci
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
JP7498925B2 (ja) 2020-08-31 2024-06-13 丸一株式会社 排水栓装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667188B2 (en) * 1990-11-27 1996-03-14 American National Red Cross, The Tissue sealant and growth factor containing compositions that promote accelerated wound healing
EP0759762A4 (fr) * 1994-05-02 1999-09-01 Squibb & Sons Inc Chaines de fibrine de recombinaison, fibrine et homologues de fibrine
ATE244584T1 (de) * 1995-01-16 2003-07-15 Baxter Int Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
WO1998055140A1 (fr) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Concentre de fibrinogene provenant de plasma humain
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
WO2000062833A1 (fr) * 1999-04-15 2000-10-26 The Research Foundation Of State University Of New York Systeme de matrice de cellules et son utilisation
JP2003500170A (ja) * 1999-06-01 2003-01-07 ブリストル−マイヤーズ スクイブ カンパニー フィブリンモノマー・シーラントを用いる術後癒着の予防

Also Published As

Publication number Publication date
US7867519B2 (en) 2011-01-11
JP5395726B2 (ja) 2014-01-22
EP1495051B1 (fr) 2008-08-06
ATE403679T1 (de) 2008-08-15
NL1020426C2 (nl) 2003-10-21
JP2010195805A (ja) 2010-09-09
JP5248547B2 (ja) 2013-07-31
JP2010246543A (ja) 2010-11-04
US20110071083A1 (en) 2011-03-24
CA2482893A1 (fr) 2003-10-23
WO2003087160A1 (fr) 2003-10-23
US20050181972A1 (en) 2005-08-18
EP1495051A1 (fr) 2005-01-12
CA2482893C (fr) 2014-08-12
JP2005538045A (ja) 2005-12-15
JP5083928B2 (ja) 2012-11-28
DE60322687D1 (de) 2008-09-18
AU2003230455A1 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
DK1495051T3 (da) Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler
DK0625056T3 (da) Kompositmembraner til reguleret regenerering af væv
DE50005818D1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
DK1635731T3 (da) Fremgangsmåde til forebyggelse af kirurgisk adhæsion
ATE265241T1 (de) Resorbierbare implantatmaterialien
ATE525100T1 (de) Poröse matrix
ATE196093T1 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
ATE200630T1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
DK1545565T3 (da) Sammensætninger, som indeholder mitotisk inaktiverede allogene fibroblaster og keratinocyter til anvendelse i regenerering af væv
NO20035569L (no) Sarbandasje og metode for kontroll av livstruende blodning
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
ATE88191T1 (de) Polypeptide mit kollagen typ iv aktivitaet.
DK1316322T3 (da) Poröse vævsstilladser til opheling og regeneration af hudvæv
WO2001050999A3 (fr) Materiaux et procedes pour transplantation os-tendon-os amelioree
DE60020526D1 (de) Osteogene pastenzusammensetzungen und ihre verwendung
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
NO20002357D0 (no) Fibrin tetningsmasse eller lim omfattende et hyaluronsyrederivat materiale
WO2002024114A3 (fr) Stents et obturateurs anastomotiques resorbables et leur utilisation chez des patients
WO2004034890A3 (fr) Matiere de support biologique
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
DK1085917T3 (da) Biomaterialer indeholdende hyaluronsyrederivater i form af tredimensionale strukturer, som er frie for cellulære komponenter eller produkter deraf, til in vivo-regenerering af vævsceller
EP4125715A4 (fr) Dispositifs d'ingénierie tissulaire in vivo, procédés et médecine régénérative et cellulaire utilisant des échafaudages constitués d'un matériau absorbable
WO2023081216A3 (fr) Implant médical auto-adhérent et son procédé d'utilisation
ATE204169T1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
Kaplan et al. Rapid Stapler Tie-Over Fixation for Skin Grafts